Time to merge!

Quote

Anonymous

Guest
Is it October yet? Is your resume up to date?

"We are still very much opposed to a large-scale combination," Lechleitr told Reuters. "We don't think size is necessarily supportive of innovation."

"We feel that (with) our current size, with the sizeable investment in research and development, we have the way to generate new medicines we need to replace the medicines that we are losing, that are coming off patent in the next several years."

How is that "best pipeline ever" Lechleitr? The amyloid drugs did more harm than good - how about those other Imclone drugs? Maybe you could sell Imclone back? Maybe you could stop buying total loser companies?
 


















I really don't understand why opposition to a merger exists.

Cost reductions achieved would result in more rapid turn around of life saving medicines.

We owe it to the patients to eliminate barriers to innovation.

With an economy of scale, redundant leadership can instead be focused on answers that matter - for example, John could use his PhD to do some groundbreaking research.

Likewise, let the MDs and PharmDs do what they do best. Free them up to do science.
 






Anonymous said:
I really don't understand why opposition to a merger exists.

Cost reductions achieved would result in more rapid turn around of life saving medicines.

We owe it to the patients to eliminate barriers to innovation.

With an economy of scale, redundant leadership can instead be focused on answers that matter - for example, John could use his PhD to do some groundbreaking research.

Likewise, let the MDs and PharmDs do what they do best. Free them up to do science.
Click to expand...

VOTE YOUR PROXY TO ELIMINATE SUPERMAJORITY VOTE FOR CHANGE-OF-CONTROL OF THE BOD Time to push this elephantine corpse called Lillie over the cliff. Bye Bye Ind'danaplis bye bye....start planting them trees in the freeway.
 






Anonymous said:
VOTE YOUR PROXY TO ELIMINATE SUPERMAJORITY VOTE FOR CHANGE-OF-CONTROL OF THE BOD Time to push this elephantine corpse called Lillie over the cliff. Bye Bye Ind'danaplis bye bye....start planting them trees in the freeway.
Click to expand...

The trees have been planted.

The Lilly crematoriums will be established near the exit gates at each facility. Next of kin will receive a supplemental death benefit for those who will not contest the unemployment compensation fraud by virtue of .... being dead.
 






All right, enough with the morbid jokes. Our careers are all guaranteed for less than the length of an FDE's so point well taken, but let's move on, shall we???

Regarding a suitor ... I would tend to think "maybe another pharma with some exposure to consumer goods" which may fit in well with the animal health, lactation hormone, puppy prozac, and anti-anxiety, depression, psychosis, and cancer drugs.

Maybe jnj or gsk.

In any case, Lilly does not have much to offer, and it just gets worse by the day. The management has an obligation to shareholders, retirees, and patients to ensure some kind of future - and the road we are traveling on now is not only full of ruts and potholes, but there are many bridges out not far ahead.
 






Anonymous said:
All right, enough with the morbid jokes. Our careers are all guaranteed for less than the length of an FDE's so point well taken, but let's move on, shall we???

Regarding a suitor ... I would tend to think "maybe another pharma with some exposure to consumer goods" which may fit in well with the animal health, lactation hormone, puppy prozac, and anti-anxiety, depression, psychosis, and cancer drugs.

Maybe jnj or gsk.

In any case, Lilly does not have much to offer, and it just gets worse by the day. The management has an obligation to shareholders, retirees, and patients to ensure some kind of future - and the road we are traveling on now is not only full of ruts and potholes, but there are many bridges out not far ahead.
Click to expand...

I doubt that there are too many suitors out there willing to merge with Lilly, rather I suspect many who might have been tempted in the past are now vulture like, watching and waiting for the inevitable implosion set to take place over the next couple of years and ready to pick over Lilly's emaciated corpse for any remaining flesh, not that I believe there will be much flesh to chew on.

Plus who do hell are these people that think Lilly will be in any position to merge at all? I mean seriously guys, the best that anyone can expect is to be bought out and for Lilly to become another lost civilisation (I say civilisation in the loosest of terms when referring to Lilly by the way). I for one will shed no tear for the demise of this rotten cess pool of a corporation, nor for it's peacocks who sneered down their noses at so many for so long. In fact I have a nice bottle of Champaigne and a Havana in storage especially for the occasion.
 












Anonymous said:
http://www.reuters.com/article/2011/03/19/lilly-idUSTOE72I00D20110319
Click to expand...

"We feel that (with) our current size, with the sizeable investment in research and development, we have the way to generate new medicines we need to replace the medicines that we are losing, that are coming off patent in the next several years."

In summary, "Six Sigma Teams have had Astounding Success at Drug Discovery even with no Drug Discovery department in Place. If we cut even more Staff, not only in Research, but also in Development, we can eliminate more bottlenecks from our Six Sigma Flow Diagram, and in this way Accelerate Imaginary Molecules through the MBA Fantasy Fully Integrated Network. It's simply That Simple."
 






Anonymous said:
"We feel that (with) our current size, with the sizeable investment in research and development, we have the way to generate new medicines we need to replace the medicines that we are losing, that are coming off patent in the next several years."

In summary, "Six Sigma Teams have had Astounding Success at Drug Discovery even with no Drug Discovery department in Place. If we cut even more Staff, not only in Research, but also in Development, we can eliminate more bottlenecks from our Six Sigma Flow Diagram, and in this way Accelerate Imaginary Molecules through the MBA Fantasy Fully Integrated Network. It's simply That Simple."
Click to expand...

You could not be more correct. That is the heart of the AIM approach. It will propel the company forward as we pay ever larger dividends on ever smaller revenues, moving forward.
 
























We have had so much talk about "leaders" for the past few years. Yet all I see are bald-headed twenty somethings parading like tyrannosaurus rex trying to find a chance to test their "new, lower and more authoritative voice" --- it's a joke.

If Lilly can't grow it's own leaders, get them from somewhere else, ASAP.
 


















"Likewise, let the MDs and PharmDs do what they do best. Free them up to do science."

MD's have been the dragging anchor holding discovery back, opinionated and without knowledge of how drugs are truly discoverd the likes of Paul, Chin, Bredt will not be missed. What lilly needs are pharmacologists with ability NOT MD's
 






Anonymous said:
"Likewise, let the MDs and PharmDs do what they do best. Free them up to do science."

MD's have been the dragging anchor holding discovery back, opinionated and without knowledge of how drugs are truly discoverd the likes of Paul, Chin, Bredt will not be missed. What lilly needs are pharmacologists with ability NOT MD's
Click to expand...

IMO MDs should be kept in the loop at some level, especially... practicing physicians.

Who better would know what drugs REALLY do to REAL people?

Of course, industry might want to keep us in the dark.
 






Anonymous said:
IMO MDs should be kept in the loop at some level, especially... practicing physicians.

Who better would know what drugs REALLY do to REAL people?

Of course, industry might want to keep us in the dark.
Click to expand...
I agree that practicing physicians understand what drugs do to people, but unfortunately very few of them understand as much about creating new drugs as they believe they do. In reality it can't be a case of either/or, but needs to have both the basic science (biology, pharmacology, medicinal chemistry) and the clinical/medical input to make it work. Having both is unfortunately rare, but always necessary.
 






Top Bottom
Back
Quote